SLC19A3 and Huntington disease: Interestingly, mutations in TPK1 are linked to Thiamine Metabolism Dysfunction Syndrome 5, which pheno-copies HD, and mutations in thiamine transporters such as SLC19A3 lead to biotin responsive basal ganglia disease77 which is treated with high T&B supplementation.